Terms: = Sarcomas AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Prognosis
20 results:
1. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
Li G; Lei J; Xu D; Yu W; Bai J; Wu G
Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
[TBL] [Abstract] [Full Text] [Related]
2. Therapeutic effects of adriamycin combined with high-intensity focused ultrasound on osteosarcoma.
Wang C
J BUON; 2019; 24(2):826-831. PubMed ID: 31128042
[TBL] [Abstract] [Full Text] [Related]
3. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
Guo Z; Tang Y; Fu Y; Wang J
Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
[TBL] [Abstract] [Full Text] [Related]
4. High-dose interleukin 2 in patients with metastatic renal cell carcinoma with sarcomatoid features.
Achkar T; Arjunan A; Wang H; Saul M; Davar D; Appleman LJ; Friedland D; Parikh RA
PLoS One; 2017; 12(12):e0190084. PubMed ID: 29261796
[TBL] [Abstract] [Full Text] [Related]
5. Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2.
Meazza C; Cefalo G; Massimino M; Daolio P; Pastorino U; Scanagatta P; Morosi C; Podda M; Ferrari A; Terenziani M; Spreafico F; Casanova M; Parafioriti A; Collini P; Gandola L; Bastoni S; Biassoni V; Schiavello E; Chiaravalli S; Puma N; Bergamaschi L; Luksch R
Med Oncol; 2017 Nov; 34(12):191. PubMed ID: 29094224
[TBL] [Abstract] [Full Text] [Related]
6. Current Status of Biological Therapies for the Treatment of Metastatic Melanoma.
Tang T; Eldabaje R; Yang L
Anticancer Res; 2016 Jul; 36(7):3229-41. PubMed ID: 27354579
[TBL] [Abstract] [Full Text] [Related]
7. Vγ9Vδ2 T cells and zoledronate mediate antitumor activity in an orthotopic mouse model of human chondrosarcoma.
Sun L; Li Y; Jiang Z; Zhang J; Li H; Li B; Ye Z
Tumour Biol; 2016 Jun; 37(6):7333-44. PubMed ID: 26676633
[TBL] [Abstract] [Full Text] [Related]
8. Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.
Valpione S; Martinoli C; Fava P; Mocellin S; Campana LG; Quaglino P; Ferrucci PF; Pigozzo J; Astrua C; Testori A; Chiarion-Sileni V
Eur J Cancer; 2015 Sep; 51(14):2086-94. PubMed ID: 26227432
[TBL] [Abstract] [Full Text] [Related]
9. [Evaluation of selected cytokines in children and adolescents with osteosarcoma at diagnosis - preliminary report].
Markiewicz K; Zeman K; Kozar A; Gołebiowska-Wawrzyniak M
Med Wieku Rozwoj; 2011; 15(1):25-31. PubMed ID: 21786509
[TBL] [Abstract] [Full Text] [Related]
10. The serum levels of soluble interleukin-2 receptor alpha and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas.
Bien E; Rapala M; Krawczyk M; Balcerska A
J Cancer Res Clin Oncol; 2010 Feb; 136(2):293-305. PubMed ID: 19693535
[TBL] [Abstract] [Full Text] [Related]
11. Poor prognosis osteosarcoma: new therapeutic approach.
Fagioli F; Biasin E; Mereuta OM; Muraro M; Luksch R; Ferrari S; Aglietta M; Madon E
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S131-4. PubMed ID: 18545234
[TBL] [Abstract] [Full Text] [Related]
12. Cardiac angiosarcoma with right atrial perforation and cardiac tamponade.
Sakaguchi M; Minato N; Katayama Y; Nakashima A
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):145-8. PubMed ID: 16702940
[TBL] [Abstract] [Full Text] [Related]
13. Feasibility of high-dose interleukin-2 in heavily pretreated pediatric cancer patients.
Schwinger W; Klass V; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Schwantzer G; Urban C
Ann Oncol; 2005 Jul; 16(7):1199-206. PubMed ID: 15849223
[TBL] [Abstract] [Full Text] [Related]
14. Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel.
Isogai R; Kawada A; Aragane Y; Tezuka T
J Dermatol; 2004 Apr; 31(4):335-41. PubMed ID: 15187330
[TBL] [Abstract] [Full Text] [Related]
15. Active chemotherapy for bone metastasis in sarcomatoid renal cell carcinoma.
Hoshi S; Satoh M; Ohyama C; Hiramatu M; Watanabe R; Hagisawa S; Endo M; Arai Y
Int J Clin Oncol; 2003 Apr; 8(2):113-7. PubMed ID: 12720105
[TBL] [Abstract] [Full Text] [Related]
16. In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors.
Bönig H; Laws HJ; Wundes A; Verheyen J; Hannen M; Kim YM; Banning U; Nürnberger W; Körholz D
Bone Marrow Transplant; 2000 Jul; 26(1):91-6. PubMed ID: 10918410
[TBL] [Abstract] [Full Text] [Related]
17. Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center report.
Laws HJ; Burdach S; van Kaick B; Engel B; Dirksen U; Körholz D; Pape H; Kahn T; Merck H; Schmitz M; Heyll A; Dockhorn-Dworniczak B; Jürgens H; Göbel U
Strahlenther Onkol; 1999 Oct; 175(10):488-94. PubMed ID: 10554643
[TBL] [Abstract] [Full Text] [Related]
18. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.
Cangiano T; Liao J; Naitoh J; Dorey F; Figlin R; Belldegrun A
J Clin Oncol; 1999 Feb; 17(2):523-8. PubMed ID: 10080595
[TBL] [Abstract] [Full Text] [Related]
19. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
[TBL] [Abstract] [Full Text] [Related]
20. [Cytotoxic activity of autologous lymphocytes against lung cancer cells; correlation of prognosis and recurrence pattern].
Kimura H; Yamaguchi Y
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2885-9. PubMed ID: 3499120
[TBL] [Abstract] [Full Text] [Related]
